What is NDC 71335-3060?

71335-3060 is the product NDC for Gabapentin, Gabapentin 600 mg/1 tablet, listed with the FDA by Bryant Ranch Prepack. It has 10 package NDCs, shown above in 10- and 11-digit form.

Bryant Ranch Prepack, NDC labeler code 71335. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Gabapentin?

561 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Gabapentin NDC 71335-3060 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)71335-3060Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71335-3060Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
71335-3060-0	7133530600071335306000	28 TABLET in 1 BOTTLE (71335-3060-0)Marketed from Feb 5, 2026
71335-3060-1	7133530600171335306001	30 TABLET in 1 BOTTLE (71335-3060-1)Marketed from Feb 5, 2026
71335-3060-2	7133530600271335306002	60 TABLET in 1 BOTTLE (71335-3060-2)Marketed from Feb 5, 2026
71335-3060-3	7133530600371335306003	180 TABLET in 1 BOTTLE (71335-3060-3)Marketed from Feb 5, 2026
71335-3060-4	7133530600471335306004	90 TABLET in 1 BOTTLE (71335-3060-4)Marketed from Feb 5, 2026
71335-3060-5	7133530600571335306005	100 TABLET in 1 BOTTLE (71335-3060-5)Marketed from Feb 5, 2026
71335-3060-6	7133530600671335306006	120 TABLET in 1 BOTTLE (71335-3060-6)Marketed from Feb 5, 2026
71335-3060-7	7133530600771335306007	500 TABLET in 1 BOTTLE (71335-3060-7)Marketed from Feb 5, 2026
71335-3060-8	7133530600871335306008	84 TABLET in 1 BOTTLE (71335-3060-8)Marketed from Feb 5, 2026
71335-3060-9	7133530600971335306009	112 TABLET in 1 BOTTLE (71335-3060-9)Marketed from Feb 5, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Gabapentin
Generic name (nonproprietary): gabapentin
Active ingredients: Gabapentin — 600 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Bryant Ranch PrepackNDC labeler code 71335
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 217995
Marketing start: Apr 4, 2024
Listing expires: Dec 31, 2027
Other FDA classes: Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
Identifiers: Product ID 71335-3060_5d28b44b-1f62-4868-8345-acdf1df41481SPL ID 5d28b44b-1f62-4868-8345-acdf1df41481SPL set ID cc1998a7-7004-4688-8b5b-525041851d1dRxCUI 310433UNII 6CW7F3G59X

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471335306000 followed by a unit qualifier and the quantity

Package 71335-3060-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 5, 2026.

Indications (excerpt from the label)

Gabapentin Tablets are indicated for: Management of postherpetic neuralgia in adults Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy Gabapentin tablets are indicated for: Postherpetic neuralgia in adults ( 1 ) Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 71335-3060

What is NDC 71335-3060?: 71335-3060 is the product NDC for Gabapentin, Gabapentin 600 mg/1 tablet, listed with the FDA by Bryant Ranch Prepack. It has 10 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Gabapentin.
What is the active ingredient?: Gabapentin.
Who is the labeler?: Bryant Ranch Prepack, NDC labeler code 71335. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Gabapentin?: 561 other product NDCs are listed under this name. See all Gabapentin NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Gabapentin NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Gabapentin	Gabapentin 800 mg/1	TabletOral	St. Mary's Medical Park Pharmacy	60760-943	60760-0943-3060760-0943-90
gabapentin	Gabapentin 300 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4763	70518-4763-00
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	Cardinal Health 107, LLC	55154-0581	55154-0581-00
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	Advanced Rx of Tennessee, LLC	80425-0595	80425-0595-0180425-0595-0280425-0595-03+1 more
Gabapentin	Gabapentin 300 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4746	70518-4746-0070518-4746-0170518-4746-02+1 more
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4742	70518-4742-0070518-4742-02
Gabapentin	Gabapentin 400 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4740	70518-4740-0070518-4740-01
Gabapentin	Gabapentin 300 mg/1	CapsuleOral	Cardinal Health 107, LLC	55154-0580	55154-0580-00
Gabapentin	Gabapentin 600 mg/1	Tablet, CoatedOral	Coupler LLC	67046-1233	67046-1233-03
Gabapentin	Gabapentin 200 mg/1	CapsuleOral	Trifluent Pharma, LLC	73352-231	73352-0231-01

All 562 Gabapentin NDCs

Other NDCs under ANDA 217995

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 217995
Product	Strength	Form · route	Labeler	Product NDC
Gabapentin	Gabapentin 800 mg/1	TabletOral	Rising Pharma Holdings, Inc.	16571-117
Gabapentin	Gabapentin 600 mg/1	TabletOral	Rising Pharma Holdings, Inc.	16571-226
Gabapentin	Gabapentin 600 mg/1	TabletOral	A-S Medication Solutions	50090-7714
Gabapentin	Gabapentin 600 mg/1	TabletOral	A-S Medication Solutions	50090-7715